Effects of flavour and modified risk claims on nicotine pouch perceptions and use intentions among young adults who use inhalable nicotine and tobacco products: a randomised controlled trial

Author:

Vogel Erin AORCID,Tackett Alayna PORCID,Unger Jennifer BORCID,Gonzalez Maria J,Peraza Natalia,Jafarzadeh Nikki S,Page Michelle KORCID,Goniewicz Maciej LORCID,Wong Melissa,Leventhal Adam MORCID

Abstract

BackgroundAvailability of flavours and potential modified risk tobacco product (MRTP) claims may influence young adults’ (YAs’) perceptions of and intentions to use nicotine pouches (‘pouches’).MethodsYAs aged 21–34 years (N=47,Mage=24.5,SD=3.1) with past-month nicotine/tobacco use (10.6% cigarette-only, 51.1% e-cigarette-only, 38.3% dual use) and no intention to quit were randomised to self-administer four Zyn 3 mg nicotine pouches in a 4 (flavour; within-subjects: smooth, mint, menthol, citrus) × 2 (MRTP claim on packaging; between subjects: present or absent) mixed-factorial design. After self-administering each pouch, participants reported appeal, use intentions and perceived harm compared with cigarettes and e-cigarettes. Three mixed-factorial analysis of variances (ANOVAs) examined main and interactive effects of flavour and MRTP claim on appeal, use intentions and comparative harm perceptions.ResultsMint (M=55.9,SD=26.4), menthol (M=49.7,SD=26.8) and citrus (M=46.6,SD=24.8) flavours were significantly more appealing than smooth (M=37.6,SD=25.4; p<0.001). MRTP claim did not significantly affect product appeal (p=0.376). Use intentions were greater for mint (M=2.6,SD=1.3) and menthol (M=2.0,SD=1.1) flavours than smooth (M=1.8,SD=1.0; p=0.002). Flavour did not affect comparative harm perceptions (p values>0.418). MRTP claims increased use intention (p=0.032) and perceptions of pouches as less harmful than cigarettes (p=0.011), but did not affect perceived harm relative to e-cigarettes (p=0.142). Flavour × MRTP claim interactions were not significant.ConclusionsFlavoured (vs smooth) pouches were more appealing to YAs. MRTP claims reduced perceived harm of pouches compared with cigarettes; however, intentions to switch were low. To protect YAs’ health, regulatory restrictions could target flavours and MRTP claims.

Funder

National Cancer Institute

National Heart, Lung, and Blood Institute

Tobacco Settlement Endowment Trust

National Institute on Drug Abuse

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health (social science)

Reference42 articles.

1. Initial information on a novel nicotine product;Plurphanswat;American J Addict,2020

2. Tobacco control research group . Nicotine pouches. In: Rowell A , Chamberlain P , eds. Tobacco Tactics. Bath, U.K: University of Bath, 2021.

3. Chowdhury A , Gill N , Hsu J . FDA receives authorization to regulate synthetic nicotine. National Law Review 2022;75.

4. Majmundar A , Okitondo C , Xue A , et al . Nicotine pouch sales trends in the US by volume and nicotine concentration levels from 2019 to 2022. JAMA Netw Open 2022;5. doi:10.1001/jamanetworkopen.2022.42235

5. Chemical characterization of tobacco-free ‘modern oral nicotine pouches and their position on the Toxicant and risk Continuums;Azzopardi;Drug Chem Toxicol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3